tykhr
sign in
free sign up
Actuate Therapeutics, Inc. Common stock
Biotechnology
Healthcare
ACTU
19.53 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
6.76
52 week high
11.00
high
7.47
52 week low
5.80
low
6.51
growth
-15.06 %
previous Close
6.97
P/E ratio
market cap
153 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-5.97 M
9.15 %
eps
0.00 %
9.15 %
eps surprise
0.00 %
net profit margin
-597096100.00 %
0.00 %
operating incoming
-5.39 M
0.78 %
net change in cash
13.17 M
867.32 %
cash on hand
13.52 M
3.00 %
cost of revenue
0.00 %
top